In terms of kidney fibrosis, Sakai et al. showed that renal fibrosis involves angiotensin II and its two receptors, AT1R (whose blockade reduces the risk of renal disease) and AT2R (which appears to counter the effects of AT1R and thus is organoprotective). The gene discussed is AGTR1; the disease is kidney disorder.